Tandem Diabetes Care, Inc.TNDMNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+9.7%
5Y CAGR+16.7%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+9.7%/yr
vs +33.6%/yr prior
5Y CAGR
+16.7%/yr
Recent deceleration
Acceleration
-24.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.2x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$443.02M+13.6%
2024$389.82M+10.6%
2023$352.50M+5.0%
2022$335.68M+28.4%
2021$261.51M+27.6%
2020$204.90M+23.6%
2019$165.74M+57.5%
2018$105.23M+21.8%
2017$86.38M+4.3%
2016$82.83M-